News and Publications

BioMed Transition Partners Announces a Biomanufacturing Initiative;
David E. Jackson Joins BioMed as a Partner to Lead the Initiative

Press Release, November 8, 2011

An Interview with Vijay Aggarwal, Ph.D.

Newsletter, September 26, 2011

Shmuel Einav, Ph.D. Joins BioMed Transition Partners as an Advisory Partner

Press Release, May 17, 2011

Vijay Aggarwal, Ph.D. Appointed to the Board of Directors of HYCOR Biomedical, Inc.

Press Release, May 16, 2011

SuperGen and Astex Therapeutics Enter Definitive Merger Agreement

Allan Goldberg serves as a member of SuperGen's Board of Directors and
Chairman of its Scientific Advisory Board.

Press Release, April 6, 2011

BioMarin Pharmaceutical Acquires ZyStor Therapeutics

Allan Goldberg is a co-founder of ZyStor Therapeutics and a co-inventor of its core technology, additionally he served on ZyStor's Board of Directors.

Press Release, August 17, 2010

Phage Pharmaceuticals Launched — Receives Funding for Purchase of Assets

Partners of BioMed Transition Partners appointed to Board of Directors and Management of Phage Pharmaceuticals.

Press Release, May 24, 2010

Vijay Aggarwal, Ph.D. Joins BioMed Transition Partners as a Partner

Press Release, December 3, 2009

E-Z-EM to Merge with Bracco Diagnostics in $241 Million Transaction

Robert Beckman served on the Executive Committee of E-Z-EM, Inc.

Press Release, October 30, 2007

Living Cell Technologies Enhances U.S. Capabilities: Appoints Members of BioMed Transition Partners to Lead Commercial and Capital Markets Initiatives

Press Release, July 2, 2007